Silk Road Medical Overview
Silk Road Medical (SILK) has a ROE of -36.55%, below the Healthcare sector average of 11.15%.
Get informed when a big investor buys or sells
+ Follow-36.55%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Silk Road Medical (SILK) currently reports a ROE of -36.55%. That is below the Healthcare sector average of 11.15%. Use the charts on this page to explore Silk Road Medical's ROE history and peer comparisons.
Silk Road Medical's ROE of -36.55% is lower than the Healthcare sector average of 11.15%. That is roughly 427.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Silk Road Medical's current -36.55% should be judged against Healthcare norms (sector average: 11.15%) and against SILK's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -36.55%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 11.15%. From there, open related valuation or income-statement pages for Silk Road Medical, and consider following SILK for alerts when major investors trade the stock.
Silk Road Medical is classified in the Healthcare sector. On ROE, it currently shows -36.55% versus a sector average near 11.15%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SILK with unrelated industries.
